A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Acronyms SECURE
- Sponsors Agile Therapeutics
- 16 Oct 2017 Results presented at the 2017 National Association for Family Planning (NAFFP), "The Forum", according to an Agile Therapeutics media release.
- 28 Sep 2017 According to an Agile Therapeutics media release, data from the study will be presented as a poster presentation during the North American Forum on Family Planning Annual Meeting 2017.
- 07 Sep 2017 According to an Agile Therapeutics media release, additional data from this study will be presented during the American Society for Reproductive Medicine (ASRM) Annual Congress 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History